CV Sciences (CVSI) Long-Term Deferred Tax (2012 - 2025)
CV Sciences' (CVSI) quarterly Long-Term Deferred Tax came in at $13.5 million in Q4 2025, down 1.28% year-on-year from $13.7 million in Q4 2024, and down 1.28% quarter-over-quarter from $13.7 million in Q4 2024.
CV Sciences (CVSI) Long-Term Deferred Tax (2012 - 2025) Analysis & Trends
CV Sciences has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $13.5 million for Q4 2025.
- Long-Term Deferred Tax for Q4 2025 came in at $13.5 million, down 1.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.5 million (down 1.28% YoY), and the FY2025 annual result was $13.5 million, down 1.28% from the prior year.
- Long-Term Deferred Tax came in at $13.5 million for Q4 2025 at CV Sciences, down from $13.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.9 million in Q4 2022 to a low of $13.5 million in Q4 2025.
- The 4-year median for Long-Term Deferred Tax is $15.4 million (2023), against an average of $15.6 million.
- Across the five-year window, Long-Term Deferred Tax slipped 20.28% in 2024 and decreased 1.28% in 2025, its largest moves.
- CV Sciences' Long-Term Deferred Tax stood at $17.9 million in 2022, then slipped by 4.28% to $17.1 million in 2023, then retreated by 20.28% to $13.7 million in 2024, then declined by 1.28% to $13.5 million in 2025.
- The last three Long-Term Deferred Tax figures came in at $13.5 million (Q4 2025), $13.7 million (Q4 2024), and $17.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.49 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Dec 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 17.91 Mn |
| Dec 31, 2014 | 1.51 Mn |
| Dec 31, 2013 | 960,757.00 |
| Dec 31, 2012 | 50,476.00 |